13F-HR filed by RA CAPITAL MANAGEMENT, L.P.
RA CAPITAL MANAGEMENT, L.P. filed this 13F-HR for the quarter ended 2014-03-31, filed 2014-05-15, with 35 holding rows worth $1,394,409,000.
- Accession
- 0001144204-14-031040
- Filer
- CIK 1346824
- Filed
- 2014-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2014
A holdings report, 35 entries on the cover page, a total value of $1,394,409,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,394,409,000 with VALUE read as thousands by filing date, 13F file number 028-12884. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Gilead Sciences,Inc. | 375558103 | COM | 2,400,000 | $170,064,000 | thousands by filing date | put |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 5,250,000 | $127,733,000 | thousands by filing date | call |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 6,000,000 | $108,480,000 | thousands by filing date | call |
| SANGAMO THERAPEUTICS INC | 800677106 | COM | 5,222,053 | $94,415,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 23,366,007 | $76,874,000 | thousands by filing date | |
| DICERNA PHARMACEUTICALS INC | 253031108 | COM | 2,428,571 | $68,607,000 | thousands by filing date | |
| DYAX CORP | 26746E103 | COM | 7,436,470 | $66,780,000 | thousands by filing date | |
| THERAPEUTICSMD INC | 88338N107 | COM | 9,838,449 | $62,081,000 | thousands by filing date | |
| OPHTHOTECH CORP | 683745103 | COM | 1,737,856 | $61,998,000 | thousands by filing date | |
| ENANTA PHARMACEUTICALS INC | 29251M106 | COM | 1,541,078 | $61,628,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 1,554,918 | $59,569,000 | thousands by filing date | |
| ARROWHEAD RESEARCH CORP | 042797209 | COM | 2,941,916 | $48,306,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 4,347,456 | $45,996,000 | thousands by filing date | |
| NOVAVAX INC | 670002104 | COMMON STOCK | 9,938,250 | $45,020,000 | thousands by filing date | |
| DYNAVAX TECHNOLOGIES CORP | 268158102 | COM | 17,883,954 | $32,331,000 | thousands by filing date | |
| SUNESIS PHARMACEUTICALS INC | 867328601 | COM NEW | 4,869,261 | $32,186,000 | thousands by filing date | |
| XENCOR INC | 98401F105 | COMMON STOCK | 2,725,000 | $31,964,000 | thousands by filing date | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 981,761 | $25,663,000 | thousands by filing date | |
| REPROS THERAPEUTICS INC | 76028H209 | COM | 1,439,048 | $25,529,000 | thousands by filing date | |
| TESARO INC | 881569107 | COM | 700,000 | $20,636,000 | thousands by filing date | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 1,169,084 | $18,822,000 | thousands by filing date | |
| DERMA SCIENCES INC | 249827502 | COM PAR $.01 | 1,339,039 | $16,979,000 | thousands by filing date | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 656,767 | $12,525,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 467,418 | $10,629,000 | thousands by filing date | |
| PSIVIDA CORP | 74440J101 | COM | 2,555,659 | $10,478,000 | thousands by filing date | |
| INTERMUNE INC | 45884X103 | COM | 300,801 | $10,068,000 | thousands by filing date | |
| ACHILLION PHARMACEUTICALS IN | 00448Q201 | COM | 3,000,000 | $9,870,000 | thousands by filing date | call |
| FLEXION THERAPEUTICS INC | 33938J106 | COM | 450,000 | $7,403,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 250,000 | $6,083,000 | thousands by filing date | |
| OCERA THERAPEUTICS INC COM | 67552A108 | COM | 527,797 | $5,568,000 | thousands by filing date | |
| MACROGENICS INC | 556099109 | COM | 199,398 | $5,549,000 | thousands by filing date | |
| ALIMERA SCIENCES INC | 016259103 | COM | 666,667 | $5,260,000 | thousands by filing date | |
| MEI PHARMA INC | 55279B202 | COM NEW | 408,333 | $4,545,000 | thousands by filing date | |
| DYAX CORP | 26746E103 | COM | 500,000 | $4,490,000 | thousands by filing date | call |
| PRANA BIOTECHNOLOGY LTD | 739727105 | SPONSORED ADR | 100,000 | $280,000 | thousands by filing date | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001144204-14-031040 | this filing | 2014-05-15 | acceptance time not in the bulk data set |